Back

prof. dr. J.M. (Jaap) van Laar

prof. dr. J.M. (Jaap) van Laar

Full Professor

Show full profile

Research Output (318)

Revisiting B cell tolerance and autoantibodies in seropositive and seronegative autoimmune rheumatic disease (AIRD)

Pouw J N Juliëtte, Leijten E F A Emmerik, van Laar J M Jacob, Boes M Marianne 15 Nov 2020, In: Clinical and Experimental Immunology. 203 , p. 160-173 14 p.

Tocilizumab in systemic sclerosis:a randomised, double-blind, placebo-controlled, phase 3 trial

Khanna Dinesh, Lin Celia J F, Furst Daniel E, Goldin Jonathan, Kim Grace, Kuwana Masataka, Allanore Yannick, Matucci-Cerinic Marco, Distler Oliver, Shima Yoshihito, van Laar Jacob M, Spotswood Helen, Wagner Bridget, Siegel Jeffrey, Jahreis Angelika, Denton Christopher P, Oct 2020, In: The Lancet Respiratory Medicine. 8 , p. 963-974 12 p.

From “being at war” to “getting back on your feet”:A qualitative study on experiences of patients with systemic sclerosis treated with hematopoietic stem cell transplantation

Spierings Julia, de Bresser Carolijn J.M., van Rhijn-Brouwer Femke C.C., Pieterse Arwen, Vonk Madelon C., Voskuyl Alexandre E., de Vries-Bouwstra Jeska K., van Laar Jacob M., Kars Marijke C. Oct 2020, In: Journal of Scleroderma and Related Disorders. 5 , p. 202-209

CXCL4 Links Inflammation and Fibrosis by Reprogramming Monocyte-Derived Dendritic Cellsin vitro

Silva-Cardoso Sandra C., Tao Weiyang, Angiolilli Chiara, Lopes Ana P., Bekker Cornelis P. J., Devaprasad Abhinandan, Giovannone Barbara, van Laar Jaap, Cossu Marta, Marut Wioleta, Hack Erik, de Boer Rob J., Boes Marianne, Radstake Timothy R. D. J., Pandit Aridaman 17 Sep 2020, In: Frontiers in Immunology. 11

Effectiveness and safety over 3 years after the 2-year U-Act-Early trial of the strategies initiating tocilizumab and/or methotrexate

Verhoeven Maxime M.A., Tekstra Janneke, Welsing Paco M.J., Pethö-Schramm Attila, Borm Michelle E.A., Bruyn George A.W., Bos Reinhard, Griep Ed N., Klaasen Ruth, van Laar Jacob M., Lafeber Floris P.J.G., Bijlsma Johannes W.J., de Hair Marjolein J.H., Jacobs Johannes W.G. 1 Sep 2020, In: Rheumatology (Oxford, England). 59 , p. 2325-2333 9 p.

B(effector)reaking bad in systemic sclerosis:role of a novel B cell subset

O'Reilly S, van Laar J Sep 2020, In: Clinical and Experimental Immunology. 201 , p. 231-232 2 p.

Effect on costs and quality-adjusted life-years of treat-to-target treatment strategies initiating methotrexate, or tocilizumab, or their combination in early rheumatoid arthritis

Verhoeven Maxime M.A., Tekstra Janneke, van Laar Jacob M., Pethö-Schramm Attila, Borm Michelle E.A., Bijlsma Johannes W.J., Jacobs Johannes W.G., Lafeber Floris P.J.G., Welsing Paco M.J. 1 Aug 2020, In: Journal of Rheumatology. 48 , p. 495-503 9 p.

Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis:results of a long-term follow-up multicentre study

van Bijnen Sandra, de Vries-Bouwstra Jeska, van den Ende Cornelia H, Boonstra Maaike, Kroft Lucie, Geurts Bram, Snoeren Miranda, Schouffoer Anne, Spierings Julia, van Laar Jacob M, Huizinga Tom Wj, Voskuyl Alexandre, Marijt Erik, van der Velden Walter, van den Hoogen Frank Hj, Vonk Madelon C Aug 2020, In: Annals of the Rheumatic Diseases. 79 , p. 1084-1089 6 p.

Clinical practice guidelines adherence, knowledge and awareness in rare and complex connective tissue diseases across Europe:results from the first ERN ReCONNET survey

Talarico Rosaria, Marinello Diana, Bombardieri Stefano, Burmester Gerd, Fonseca Joao, Frank Charissa, Galetti Ilaria, Hachulla Eric, Houssiau Frederic, Mueller-Ladner Ulf, Schneider Matthias, Smith Vanessa, Turchetti Giuseppe, van Laar Jacob M, Vieira Ana, Cutolo Maurizio, Mosca Marta Aug 2020, In: RMD Open. 6 , p. 1-12

Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA):a double-blind, multicentre, randomised controlled trial

Burmester Gerd R, Buttgereit Frank, Bernasconi Corrado, Álvaro-Gracia Jose M, Castro Nidia, Dougados Maxime, Gabay Cem, van Laar Jacob M, Nebesky Jan Michael, Pethoe-Schramm Attila, Salvarani Carlo, Donath Marc Y, John Markus R, 25 Jul 2020, In: The Lancet. 396 , p. 267-276 10 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not